TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/10/24 17:56 | 1/8/24 | OPK | Opko Health, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Nabel Gary J. | FL | DO | Chief In | P | 200 | 0.9271 | 0 | 216 | 1 | 40,547 | I | ||||||||||||||
6/15/23 17:15 | 6/13/23 | SIGA | Siga Technologies Inc | DE | Health | Drug | Pharmaceutical Preparations | Nabel Gary J. | NY | D | M.d | 0 | 0.00 | 0 | 15 | 126 | 26 | D | |||||||||||||||
5/8/23 07:03 | 5/5/23 | OPK | Opko Health, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Nabel Gary J. | FL | DO | Chief In | P | 841 | 1.83 | 0 | 460 | 999% | 506 | M | ||||||||||||||
6/24/22 19:52 | 6/22/22 | OPK | Opko Health, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Nabel Gary J. | FL | DO | Chief In | P | 597 | 2.49 | 0 | 240 | 1 | 39,870 | I | ||||||||||||||
6/16/22 17:47 | 6/14/22 | SIGA | Siga Technologies Inc | DE | Health | Drug | Pharmaceutical Preparations | Nabel Gary J. | NY | D | M.d | 0 | 0.00 | 0 | 23 | 16 | D | ||||||||||||||||
5/19/22 16:28 | 5/12/22 | OPK | Opko Health, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Nabel Gary J. | FL | DO | Chief In | P.m | 217 | 2.88 | 0 | 75 | New | 75 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |